Skip to content

Clinical trials

Mesothelioma, Malignant trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Country / region: Belgium Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20091
20102
20132
20152
20162
20171
20181
20221
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status3
Active, not recruiting2
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC5
University Hospital, Antwerp4
AGC Biologics S.p.A.1
AstraZeneca1
Cancer Trials Ireland1
European Lung Cancer Working Party1
Jules Bordet Institute1
MedImmune LLC1
NovoCure Ltd.1
Sabine Rhode1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant19
Breast Neoplasms2
Carcinoma, Renal Cell2
Colorectal Neoplasms2
Mesothelioma2
Wilms Tumor2
Appendiceal Neoplasms1
Ascites1
Carcinoma, Hepatocellular1
Carcinoma, Merkel Cell1

Trials

Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.